New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
New computational model proposed for Alzheimer's disease

New computational model proposed for Alzheimer's disease

by Susan Barber Lindquist,Mayo ClinicSurface renderings of glucose eigenbrains. Eigenbrain decomposition of glucose uptake in 423 Alzheimer’s patients reveals a low-dimensional set of large-scal
Neurology April 07,2024
New computational model proposed for Alzheimer's disease

New computational model proposed for Alzheimer's disease

by Susan Barber Lindquist,Mayo ClinicSurface renderings of glucose eigenbrains. Eigenbrain decomposition of glucose uptake in 423 Alzheimer’s patients reveals a low-dimensional set of large-scal
Neurology April 07,2024
Alzheimer's risk gene disrupts endocytosis, but another disease-linked gene could help

Alzheimer's risk gene disrupts endocytosis, but another disease-linked gene could help

by Massachusetts Institute of TechnologyAPOE4 Astrocytes showed an increase in endocytosis after overexpression of PICALM. In the bottom row, astrocytes (labeled blue), have taken up more of a pr
Neurology April 07,2024
Alzheimer's risk gene disrupts endocytosis, but another disease-linked gene could help

Alzheimer's risk gene disrupts endocytosis, but another disease-linked gene could help

by Massachusetts Institute of TechnologyAPOE4 Astrocytes showed an increase in endocytosis after overexpression of PICALM. In the bottom row, astrocytes (labeled blue), have taken up more of a pr
Neurology April 07,2024
New biological research framework for Alzheimer's seeks to spur discovery

New biological research framework for Alzheimer's seeks to spur discovery

by National Institutes of HealthThis table shows column of the eight biomarker profiles (left) and corresponding categories (right) outlined in the framework that could be used to group research
Neurology April 07,2024
New biological research framework for Alzheimer's seeks to spur discovery

New biological research framework for Alzheimer's seeks to spur discovery

by National Institutes of HealthThis table shows column of the eight biomarker profiles (left) and corresponding categories (right) outlined in the framework that could be used to group research
Neurology April 07,2024
A potential new treatment target for Alzheimer's disease

A potential new treatment target for Alzheimer's disease

by Keck School of Medicine of USCActivation of cyclophilin A (CypA; red upper panels) leads to activation of MMP9 (red lower panels) in CD13+-pericytes (green) in brain capillaries of APOE4 human
Neurology April 07,2024
A potential new treatment target for Alzheimer's disease

A potential new treatment target for Alzheimer's disease

by Keck School of Medicine of USCActivation of cyclophilin A (CypA; red upper panels) leads to activation of MMP9 (red lower panels) in CD13+-pericytes (green) in brain capillaries of APOE4 human
Neurology April 07,2024
Rate of Alzheimer's deaths on the rise

Rate of Alzheimer's deaths on the rise

by Pennsylvania State UniversityCredit: Thinkstock/monkeybusinessimagesThe rate of death from Alzheimer's disease in the United States increased by more than 50 percent in the past 15 years,
Neurology April 07,2024
Rate of Alzheimer's deaths on the rise

Rate of Alzheimer's deaths on the rise

by Pennsylvania State UniversityCredit: Thinkstock/monkeybusinessimagesThe rate of death from Alzheimer's disease in the United States increased by more than 50 percent in the past 15 years,
Neurology April 07,2024
Alzheimer's risk factors may be measurable in adolescents and young adults

Alzheimer's risk factors may be measurable in adolescents and young adults

by Alzheimer's AssociationCredit: CC0 Public DomainRisk factors for Alzheimer's dementia may be apparent as early as our teens and 20s, according to new research reported at the Alzheimer'
Neurology April 07,2024
Alzheimer's risk factors may be measurable in adolescents and young adults

Alzheimer's risk factors may be measurable in adolescents and young adults

by Alzheimer's AssociationCredit: CC0 Public DomainRisk factors for Alzheimer's dementia may be apparent as early as our teens and 20s, according to new research reported at the Alzheimer'
Neurology April 07,2024
New clues to Alzheimer's disease

New clues to Alzheimer's disease

by Alvin Powell,Harvard UniversityHarvard University McLean researchers Bruce Cohen, left, and Kai Sonntag have found an energy dysfunction in the cells of late-onset Alzheimer's patients, a
Neurology April 07,2024
New clues to Alzheimer's disease

New clues to Alzheimer's disease

by Alvin Powell,Harvard UniversityHarvard University McLean researchers Bruce Cohen, left, and Kai Sonntag have found an energy dysfunction in the cells of late-onset Alzheimer's patients, a
Neurology April 07,2024
Cerebrovascular abnormalities in Alzheimer's disease: An adrenergic approach

Cerebrovascular abnormalities in Alzheimer's disease: An adrenergic approach

by Impact Journals LLCΑ1AR-mediated downstream signaling pathway involved in Aβ-induced cerebrovascular abnormalities. Credit: Song LiAging-UShas published "Involvement of cerebrovascular a
Neurology April 07,2024
Cerebrovascular abnormalities in Alzheimer's disease: An adrenergic approach

Cerebrovascular abnormalities in Alzheimer's disease: An adrenergic approach

by Impact Journals LLCΑ1AR-mediated downstream signaling pathway involved in Aβ-induced cerebrovascular abnormalities. Credit: Song LiAging-UShas published "Involvement of cerebrovascular a
Neurology April 07,2024
New pathway in Alzheimer's disease provides earlier target for potential therapies

New pathway in Alzheimer's disease provides earlier target for potential therapies

by Case Western Reserve UniversityCredit: CC0 Public DomainResearchers at the Case Western Reserve University School of Medicine have identified a new target in development of Alzheimer's dis
Neurology April 07,2024
New pathway in Alzheimer's disease provides earlier target for potential therapies

New pathway in Alzheimer's disease provides earlier target for potential therapies

by Case Western Reserve UniversityCredit: CC0 Public DomainResearchers at the Case Western Reserve University School of Medicine have identified a new target in development of Alzheimer's dis
Neurology April 07,2024
Alzheimer's risk genes converge on microglia

Alzheimer's risk genes converge on microglia

by VIB (the Flanders Institute for Biotechnology)Credit: CC0 Public DomainDNA determines a large part of the risk for Alzheimer's disease, but it remained unclear how many genetic risk factor
Neurology April 07,2024
Alzheimer's risk genes converge on microglia

Alzheimer's risk genes converge on microglia

by VIB (the Flanders Institute for Biotechnology)Credit: CC0 Public DomainDNA determines a large part of the risk for Alzheimer's disease, but it remained unclear how many genetic risk factor
Neurology April 07,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com